Who are EpilepsyGTx's investors?

EpilepsyGTx's investors include AlbionVC, Moonstone Venture Capital, UCL Technology Fund, XGEN Venture, British Business Bank.

EpilepsyGTx

5 known investors

epilepsygtx.com ↗

EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.

BiotechDigital Health

Investors · 5

AlbionVCLondon

Moonstone Venture CapitalMilan

UCL Technology FundLondon · $320K – $9M

XGEN VentureMilan

British Business BankreportedSheffield

In the news

EpilepsyGTx secures $33m to progress FRE therapy through Phase I/IIa trialsclinicaltrialsarena.com · Dec 2025

EpilepsyGTx’s $33m Series A brings hope for 'life changing' focal refractory epilepsy treatment - 10 - 12 - 2025 - UCLBuclb.com · Dec 2025

Advising EpilepsyGTx on its US$33 million Series A financingtaylorwessing.com · Dec 2025

Gene therapy for severe epilepsy moves forward with EpilepsyGTx’s €28 million funding | EU-Startupseu-startups.com · Dec 2025

EpilepsyGTx Raises $33 Million Series A to Develop Single Dose Gene Therapy for Focal Refractory Epilepsybusinesswire.com · Dec 2025

EpilepsyGTx Raises $10M in Seed Fundingfinsmes.com · Jun 2024

Frequently asked questions

What does EpilepsyGTx do?: EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.
Who are EpilepsyGTx's investors?: EpilepsyGTx's investors include AlbionVC, Moonstone Venture Capital, UCL Technology Fund, XGEN Venture, British Business Bank.